Migraine History Tied to Higher Risk for Adverse Pregnancy Outcomes

THURSDAY, June 2, 2022 (HealthDay News) -- A self-reported migraine history is associated with a higher risk for some adverse pregnancy outcomes, according to a research letter published online April 30 in the American Journal of Obstetrics & Gynecology.
Eliza C. Miller, M.D., from Columbia University in New York City, and colleagues assessed whether self-reported migraine in nulliparous individuals is associated with higher odds of adverse pregnancy outcomes. The analysis included 9,450 nulliparous U.S. individuals with singleton gestation in early pregnancy followed through delivery.
The researchers found that 19.1 percent of participants reported a diagnosis of migraine at the first visit. White race, recent smoking history, autoimmune disorders, and chronic kidney disease were more common among participants with migraine. In an adjusted analysis, participants with migraine had increased odds of any adverse pregnancy outcome (adjusted odds ratio, 1.26), as well as any hypertensive disorder of pregnancy and both medically indicated and spontaneous preterm birth. A larger effect was seen in participants who reported recent medication use (adjusted odds ratio, 1.49).
"In a diverse, prospective cohort of 9,450 nulliparous U.S. participants, self-reported migraine headaches were associated with 26 percent higher odds of adverse pregnancy outcomes -- an effect driven by hypertensive disorders of pregnancy and both medically indicated and spontaneous preterm birth," the authors write. "Migraine may be an underrecognized risk factor for adverse pregnancy outcomes."
Related Posts
New Bill Would Ensure Free Exams for Sexual Assault Victims
THURSDAY, Oct. 27, 2022 (HealthDay News) -- After a sexual assault, some victims...
Uno de cada 4 padres dice que sus hijos han estado en cuarentena desde que comenzó la escuela
VIERNES, 1 de octubre de 2021 (HealthDay News) -- Una cuarta parte de los padres...
Program Aims to Get Lifesaving Drugs to Kids With Cancer in Poorer Countries
WEDNESDAY, Dec. 22, 2021 (HealthDay News) -- A new program to boost the supply...
Dapagliflozin Cuts CV Risk in Heart Failure With Preserved LVEF
MONDAY, Aug. 29, 2022 (HealthDay News) -- For patients with heart failure with...